These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8849216)

  • 1. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals.
    Griggs DJ; Gensberg K; Piddock LJ
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1009-13. PubMed ID: 8849216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and mechanisms of quinolone resistance among selected nontyphoid Salmonella isolated from food animals and humans in Korea.
    Tamang MD; Nam HM; Kim A; Lee HS; Kim TS; Kim MJ; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2011 Nov; 8(11):1199-206. PubMed ID: 21877929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.
    Weigel LM; Steward CD; Tenover FC
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2661-7. PubMed ID: 9756773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
    Kaneko A; Sasaki J; Shimadzu M; Kanayama A; Saika T; Kobayashi I
    J Antimicrob Chemother; 2000 Jun; 45(6):771-5. PubMed ID: 10837428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom.
    Piddock LJ; Ricci V; McLaren I; Griggs DJ
    J Antimicrob Chemother; 1998 Jun; 41(6):635-41. PubMed ID: 9687102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin.
    Bébéar CM; Grau O; Charron A; Renaudin H; Gruson D; Bébéar C
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2719-27. PubMed ID: 10991851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.
    Kim JH; Cho EH; Kim KS; Kim HY; Kim YM
    Antimicrob Agents Chemother; 1998 Jan; 42(1):190-3. PubMed ID: 9449286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the NH2-terminal 83rd amino acid of Escherichia coli GyrA in quinolone-resistance.
    Yonezawa M; Takahata M; Banzawa N; Matsubara N; Watanabe Y; Narita H
    Microbiol Immunol; 1995; 39(4):243-7. PubMed ID: 7651238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the NH2-terminal 87th amino acid of Escherichia coli GyrA in quinolone-resistance.
    Yonezawa M; Takahata M; Banzawa N; Matsubara N; Watanabe Y; Narita H
    Microbiol Immunol; 1995; 39(7):517-20. PubMed ID: 8569537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance.
    Reyna F; Huesca M; González V; Fuchs LY
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1621-3. PubMed ID: 7492118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.
    Oh H; El Amin N; Davies T; Appelbaum PC; Edlund C
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1977-81. PubMed ID: 11408211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
    Conrad S; Oethinger M; Kaifel K; Klotz G; Marre R; Kern WV
    J Antimicrob Chemother; 1996 Sep; 38(3):443-55. PubMed ID: 8889719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance.
    Goñi-Urriza M; Arpin C; Capdepuy M; Dubois V; Caumette P; Quentin C
    Antimicrob Agents Chemother; 2002 Feb; 46(2):350-9. PubMed ID: 11796341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae.
    Deguchi T; Yasuda M; Asano M; Tada K; Iwata H; Komeda H; Ezaki T; Saito I; Kawada Y
    Antimicrob Agents Chemother; 1995 Feb; 39(2):561-3. PubMed ID: 7726535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
    Ito H; Yoshida H; Bogaki-Shonai M; Niga T; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones.
    Bebear CM; Bové JM; Bebear C; Renaudin J
    Antimicrob Agents Chemother; 1997 Feb; 41(2):269-73. PubMed ID: 9021178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro.
    Dessus-Babus S; Bébéar CM; Charron A; Bébéar C; de Barbeyrac B
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2474-81. PubMed ID: 9756744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.